FR2456743A1 - Derives de naphtyridine et leur application en therapeutique - Google Patents

Derives de naphtyridine et leur application en therapeutique

Info

Publication number
FR2456743A1
FR2456743A1 FR7912176A FR7912176A FR2456743A1 FR 2456743 A1 FR2456743 A1 FR 2456743A1 FR 7912176 A FR7912176 A FR 7912176A FR 7912176 A FR7912176 A FR 7912176A FR 2456743 A1 FR2456743 A1 FR 2456743A1
Authority
FR
France
Prior art keywords
cerebral
psychotropics
indolo
pyrimido
geriatric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7912176A
Other languages
English (en)
French (fr)
Other versions
FR2456743B1 (OSRAM
Inventor
Patrick Lardenois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR7912176A priority Critical patent/FR2456743A1/fr
Publication of FR2456743A1 publication Critical patent/FR2456743A1/fr
Application granted granted Critical
Publication of FR2456743B1 publication Critical patent/FR2456743B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7912176A 1979-05-14 1979-05-14 Derives de naphtyridine et leur application en therapeutique Granted FR2456743A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7912176A FR2456743A1 (fr) 1979-05-14 1979-05-14 Derives de naphtyridine et leur application en therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7912176A FR2456743A1 (fr) 1979-05-14 1979-05-14 Derives de naphtyridine et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2456743A1 true FR2456743A1 (fr) 1980-12-12
FR2456743B1 FR2456743B1 (OSRAM) 1982-05-28

Family

ID=9225425

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7912176A Granted FR2456743A1 (fr) 1979-05-14 1979-05-14 Derives de naphtyridine et leur application en therapeutique

Country Status (1)

Country Link
FR (1) FR2456743A1 (OSRAM)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374905A2 (fr) * 1976-12-24 1978-07-21 Synthelabo Derives de naphtyridine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374905A2 (fr) * 1976-12-24 1978-07-21 Synthelabo Derives de naphtyridine

Also Published As

Publication number Publication date
FR2456743B1 (OSRAM) 1982-05-28

Similar Documents

Publication Publication Date Title
AU8610291A (en) Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
FR2492382B1 (OSRAM)
HU9202448D0 (en) Method for treatment of inflammatory diseases of eyes
CA2125888A1 (en) Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty
DE122005000005I2 (de) Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz
AU572497B2 (en) 1,2,3,4-tetrahydro-2-naphthylamines
NZ183416A (en) Composition for enzymatic treatment of cataract
ES2068862T3 (es) Derivado de 3'-hidroxibenzoxazinorifamicina; procedimiento para la preparacion del mismo y agente antibacteriano que contiene el mismo.
TW372237B (en) 1-2-4 triazolo[1,5-a]pyrimidines, pharmaceutical compositions containing them for treatment and/or prophylaxis of seizures, neurological disorders and/or conditions in which there is neurological damage, and processes for their preparation
IE40860B1 (en) Substituted benzamides
RU94039284A (ru) Производные пиперазина, способ их получения, фармкомпозиция и ее использование
HU9500997D0 (en) Substituted kynurenines, a process for their preparation, and use as medicaments
FR2456743A1 (fr) Derives de naphtyridine et leur application en therapeutique
AU3329293A (en) Method of imparting antimicrobial activity to an ophthalmic composition
ATE28193T1 (de) 2-anilino-1,6-dihydro-6-oxo-5pyrimidincarbons|ure-derivate, verfahren zu ihrer herstellung, und diese enthaltende antiallergische wirkstoffe.
DE3160044D1 (en) 2,3-dihydroimidazo (1,2-b) pyridazine derivatives, process for their preparation and their therapeutical use
AU2431984A (en) Shampoo Composition of Neostigmine or Pyridostigmine
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
EP0260790A3 (en) Use of pinacidil in the treatment of incontinence
EP0255145A3 (de) Verwendung von Tetrachlordecaoxid in der Ophthalmologie
Burn EXPERIENCE IN TREATMENT OF EXTENSIVE FULL-THICKNESS BURNS
ZA806085B (en) Therapeutic compositions for treatment of glaucoma
HUT45062A (en) Process for producing 1-hydroxy-5-oxo-5h-pindo/3,2-a/ phenoxazine-3-carboxylic acid esters and pharmaceuticals comprising the same as active ingredient
Lugossy et al. After the abrasion of the cornea, visual acuity increased to 1.0 in the right eye and 0.15 in the left eye.
DE59107405D1 (de) Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen

Legal Events

Date Code Title Description
ST Notification of lapse